Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Ron Nersesian; Guy Sene; Marc Williams; Janet Williams

Premium

Agilent Technologies has appointed Ron Nersesian as executive vice president and chief operating officer. For the past two years, Nersesian has served as president of Agilent's Electronic Measurement Group. In his new role, he will have day-to-day responsibility for the company's three businesses, Chemical Analysis, Life Sciences, and EMG.

Guy Séné, who has been vice president of the Microwave and Communications Division since 2009, will replace Nersesian as EMG president, Agilent said.


Marc Williams and Janet Williams have joined Geisinger Health System's Genomic Medicine Institute. Marc Williams will serve as senior director and director of the institute and Janet Williams will be an investigator. Both begin their roles on Jan. 1.

Geisinger has tapped Marc Williams to expand its translational research program in genomic medicine. He previously served as director of the Intermountain Healthcare Clinical Genetics Institute in Salt Lake City, where Janet Williams was coordinating genetic counselor.

Geisinger's new hires follow the appointment of David Ledbetter as chief scientific officer last year. BioArray News spoke with Ledbetter about Geisinger's interest in expanding its genomic medicine programs at that time (BAN 1/11/11).

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.